ResearcherUniversity of Chieti-PescaraActive in the last 2 years

Maria Cristina Curia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4979-887X; OpenAlex author ID A5087182273. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Intratumoral Fusobacterium nucleatum in Pancreatic Cancer: Current and Future Perspectives. Last author DOI 10.3390/pathogens14010002 ↗
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-019-5616-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Domenica Lucia D’Antonio · 1 shared paper, 2024 · strength 0.28
- Paper Intratumoral Fusobacterium nucleatum in Pancreatic Cancer: Current and Future Perspectives. DOI 10.3390/pathogens14010002 ↗
Pierluigi Di Sebastiano · 1 shared paper, 2019 · strength 0.10
- Paper High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-019-5616-2 ↗
Alessandro Cama · 1 shared paper, 2019 · strength 0.10
- Paper High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-019-5616-2 ↗
Francesca Tavano · 1 shared paper, 2019 · strength 0.10
- Paper High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-019-5616-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.